CN103083601A - Traditional Chinese medical composition for treating pompholyx - Google Patents
Traditional Chinese medical composition for treating pompholyx Download PDFInfo
- Publication number
- CN103083601A CN103083601A CN2013100652180A CN201310065218A CN103083601A CN 103083601 A CN103083601 A CN 103083601A CN 2013100652180 A CN2013100652180 A CN 2013100652180A CN 201310065218 A CN201310065218 A CN 201310065218A CN 103083601 A CN103083601 A CN 103083601A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- pompholyx
- composition
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medical composition for treating pompholyx. The raditional Chinese medical composition comprises the following active components: 20-40g of radix sophorae flavescentis, 10-30g of Schizonepeta, 20-40g of fructus cnidii, 10-30g of alum, 10-30g of cortex dictamni, 10-30g of radix sileris and 10-30g of radix stemonae. The traditional Chinese medical composition is excellent in effect, simple to prepare, convenient to use and free from toxic and side effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of pompholyx.
Background technology
Pompholyx weighs up again antiperspirant obstacle rash, is a kind of of skin eczema, the symmetric side that betides hands or foot.Be occur in the palm sole of the foot vesicle dermatoses modern operating pressure large, spirit is in high-strung state, especially some white collars, have because working environment is limit, brothers' ratio is easier to perspire, the factor such as fungal infection and allergy can cause the generation of pompholyx, and summer is hot, so pompholyx is more common in summer.Because the position that its occurs is in the flourishing especially place of this sweat gland of trick, again take blister as main performance, so former once thinking it and sweat gland sweat relevant, and with its called after pompholyx.In the property phlysis, the foxtail millet grain slightly exceeds skin surface to grain of rice size to the pompholyx symptom for deeply, and often without blush, symmetry betides the palm sole of the foot and refers to (toe) side.1-2 dries up into bits after week, and can repeatedly occur, companion's scorching hot and pruritus in various degree, and Chang Lianxu shows effect the several years.
At present, the corticosteroids medicines that adopt are treated pompholyx more, but the side effect of hormone medicine is larger, and long-time use meeting brings many harmful effects to human body, therefore is necessary to invent a kind of good effect and the little Chinese medicine composition of side effect is treated pompholyx.The present invention just is being based on above-mentioned thinking and is making.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition for the treatment of pompholyx.
In order to realize the foregoing invention purpose, one of technical scheme of the present invention is that raw material composition and the weight proportion thereof of making the said composition effective ingredient comprise: Radix Sophorae Flavescentis 20-40 part, Herba Schizonepetae 10-30 part, Fructus Cnidii 20-40 part, Alumen 10-30 part, Cortex Dictamni 10-30 part, Radix Saposhnikoviae 10-30 part, Radix Stemonae 10-30 part.
The preferred version of above-mentioned prescription is that raw material composition and the weight proportion thereof of making the said composition effective ingredient are: 30 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Schizonepetae, 30 parts of Fructus Cnidiis, 20 parts of Alumens, 20 parts of Cortex Dictamni, 20 parts of Radix Saposhnikoviaes, 20 parts of the Radixs Stemonae.
According to technique scheme, the consumption of each raw material in every secondary Chinese medicine composition is: Radix Sophorae Flavescentis 20-40g, Herba Schizonepetae 10-30g, Fructus Cnidii 20-40g, Alumen 10-30g, Cortex Dictamni 10-30g, Radix Saposhnikoviae 10-30g, Radix Stemonae 10-30 g.
In order to realize the foregoing invention purpose, two of technical scheme of the present invention is that raw material composition and the weight proportion thereof of making the said composition effective ingredient are: Radix Sophorae Flavescentis 20-40 part, Herba Schizonepetae 10-30 part, Fructus Cnidii 20-40 part, Alumen 10-30 part, Cortex Dictamni 10-30 part, Radix Saposhnikoviae 10-30 part, Radix Stemonae 10-30 part, Radix Scutellariae 10-30 part, Rhizoma Coptidis 10-30 part, Rhizoma Atractylodis 20-30 part, Pericarpium Citri Reticulatae 10-30 part, Poria 10-30 part.
The preferred version of above-mentioned prescription is that the raw material of making the said composition effective ingredient forms and weight proportion is 30 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Schizonepetae, 30 parts of Fructus Cnidiis, 20 parts of Alumens, 20 parts of Cortex Dictamni, 20 parts of Radix Saposhnikoviaes, 20 parts of the Radixs Stemonae, 20 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Rhizoma Atractylodis, 20 parts of Pericarpium Citri Reticulataes, 20 parts, Poria.
According to technique scheme, the consumption of each raw material in every secondary Chinese medicine composition is: Radix Sophorae Flavescentis 20-40g, Herba Schizonepetae 10-30g, Fructus Cnidii 20-40g, Alumen 10-30g, Cortex Dictamni 10-30g, Radix Saposhnikoviae 10-30g, Radix Stemonae 10-30g, Radix Scutellariae 10-30g, Rhizoma Coptidis 10-30g, Rhizoma Atractylodis 20-30g, Pericarpium Citri Reticulatae 10-30g, Poria 10-30g.
The main causes for causing a disease such as it is main that pompholyx shows as deep-seated vesicles, and the traditional Chinese medical science thinks that should belong to damp contains partially, and ailment said due to cold or exposure, damp, pathogenic heat, blood deficiency, worm are excessive.
Radix Sophorae Flavescentis heat clearing and damp drying in the present invention, wind dispelling insecticide; The Herba Schizonepetae loose wind that induces sweat, rash, the skin ulcer that disappears, hemostasis; The Fructus Cnidii warming the kidney to invigorate YANG, removing dampness and killing parasites, dispelling wind for relieving itching; The Alumen external parasite killing that can detoxify, dampness removing to stop itchin; Cortex Dictamni heat clearing and damp drying, dispelling wind for relieving itching, detoxifcation; Radix Saposhnikoviae expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, antipruritic; The cough-relieving of Radix Stemonae nourishing the lung to keep the adverse QI downward, parasite killing; Radix Scutellariae has heat clearing and damp drying, and removing heat from blood is antiabortive, detoxicating functions; The Rhizoma Coptidis heat clearing and damp drying, eliminating fire and detoxication; Rhizoma Atractylodis are drying damp and strengthening spleen, and expelling wind and cold makes eye bright; The Pericarpium Citri Reticulatae regulating qi-flowing for strengthening spleen, in accent, dampness is reduced phlegm; The Poria promoting diuresis to eliminate damp pathogen, invigorating the spleen for dissipating phlegm, mind tranquilizing and the heart calming relieves internal heat anticancer.All medicines share and gather altogether the prescription of dispelling wind damp eliminating, heat-clearing and toxic substances removing, blood enriching and dryness moistening, blood circulation promoting and blood stasis dispelling, to reach the antipruritic effect of the righting of getting rid of evils, are used for the pompholyx treatment, and effect is good.
Usage and dosage of the present invention is: get by formula the Chinese medicine of respectively distinguishing the flavor of and add the little fire of cold water and endured 15-20 minute, be down to cool or bubble hands 15-20 minute during non-scald on hand etc. water temperature.Steep one to three time, an auxiliary medicine every day with 4 days.Used time heats and gets final product, and is not boiled, can not add cold water again.Generally can cure fully with the 2-3 auxiliary medicine during severe symptoms.
The invention has the advantages that: effect is good, makes simply, and is easy to use, has no side effect.
Below by clinical experiment, curative effect of the present invention is verified.
1, case is selected: choose at random 86 patients, wherein male 44 people, female 42 people, maximum 89 years old, minimum 15 years old, 43 years old mean age, be divided into treatment group (male 22 people, female 21 people) and matched group (male 22 people, female 21 people).
2, Therapeutic Method: treatment cycle is 14 days, and treatment group uses the liquid that boils of Chinese medicine composition of the present invention to soak, every day 3 times; Matched group is smeared fluocinonide ointment, every day 3 times.
3, curative effect determinate standard: recovery from illness, herpes all disappears or only stays the small pieces skin lesion; Take a turn for the better, the herpes 50-80% that disappears; Invalid, after treatment, skin lesion has no improvement or reviews deterioration.The case load that recovery from illness adds improvement is total effectively case.
4, therapeutic outcome: recovery from illness 23 examples in treatment group, 18 examples that take a turn for the better, invalid 2 examples, total effective rate is 95.3%; Recovery from illness 12 examples in matched group, 17 examples that take a turn for the better, invalid 14 examples, total effective rate is 67.4%.
By above-mentioned clinical verification, illustrate that therapeutic effect of the present invention is good, effective percentage is high.
The specific embodiment
Embodiment 1
The Chinese medicine composition for the treatment of pompholyx, its raw material form to be counted by weight: Radix Sophorae Flavescentis 20g, Herba Schizonepetae 10g, Fructus Cnidii 20g, Alumen 10g, Cortex Dictamni 10g, Radix Saposhnikoviae 10g, Radix Stemonae 10g.
Embodiment 2
The Chinese medicine composition for the treatment of pompholyx, its raw material form to be counted by weight: Radix Sophorae Flavescentis 30g, Herba Schizonepetae 20g, Fructus Cnidii 30g, Alumen 20g, Cortex Dictamni 20g, Radix Saposhnikoviae 20g, Radix Stemonae 20g.
Embodiment 3
The Chinese medicine composition for the treatment of pompholyx, its raw material form to be counted by weight: Radix Sophorae Flavescentis 40g, Herba Schizonepetae 30g, Fructus Cnidii 40g, Alumen 30g, Cortex Dictamni 30g, Radix Saposhnikoviae 30g, Radix Stemonae 30g.
Embodiment 4
The Chinese medicine composition for the treatment of pompholyx, its raw material form to be counted by weight: Radix Sophorae Flavescentis 20g, Herba Schizonepetae 10g, Fructus Cnidii 20g, Alumen 10g, Cortex Dictamni 10g, Radix Saposhnikoviae 10g, Radix Stemonae 10g, Radix Scutellariae 10g, Rhizoma Coptidis 10g, Rhizoma Atractylodis 20g, Pericarpium Citri Reticulatae 10g, Poria 10g.
Embodiment 5
The Chinese medicine composition for the treatment of pompholyx, its raw material form to be counted by weight: Radix Sophorae Flavescentis 30g, Herba Schizonepetae 20g, Fructus Cnidii 30g, Alumen 20g, Cortex Dictamni 20g, Radix Saposhnikoviae 20g, Radix Stemonae 20g, Radix Scutellariae 20g, Rhizoma Coptidis 20g, Rhizoma Atractylodis 20g, Pericarpium Citri Reticulatae 20g, Poria 20g.
Embodiment 6
The Chinese medicine composition for the treatment of pompholyx, its raw material form to be counted by weight: Radix Sophorae Flavescentis 40g, Herba Schizonepetae 40g, Fructus Cnidii 40g, Alumen 30g, Cortex Dictamni 30g, Radix Saposhnikoviae 30g, Radix Stemonae 30g, Radix Scutellariae 30g, Rhizoma Coptidis 30g, Rhizoma Atractylodis 30g, Pericarpium Citri Reticulatae 30g, Poria 30g.
Claims (4)
1. a Chinese medicine composition for the treatment of pompholyx, is characterized in that raw material composition and the weight proportion thereof of making the said composition effective ingredient comprise: Radix Sophorae Flavescentis 20-40 part, Herba Schizonepetae 10-30 part, Fructus Cnidii 20-40 part, Alumen 10-30 part, Cortex Dictamni 10-30 part, Radix Saposhnikoviae 10-30 part, Radix Stemonae 10-30 part.
2. the Chinese medicine composition for the treatment of pompholyx according to claim 1, is characterized in that raw material composition and the weight proportion thereof of making the said composition effective ingredient are: 30 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Schizonepetae, 30 parts of Fructus Cnidiis, 20 parts of Alumens, 20 parts of Cortex Dictamni, 20 parts of Radix Saposhnikoviaes, 20 parts of the Radixs Stemonae.
3. the Chinese medicine composition for the treatment of pompholyx according to claim 1, is characterized in that raw material composition and the weight proportion thereof of making the said composition effective ingredient are: Radix Sophorae Flavescentis 20-40 part, Herba Schizonepetae 10-30 part, Fructus Cnidii 20-40 part, Alumen 10-30 part, Cortex Dictamni 10-30 part, Radix Saposhnikoviae 10-30 part, Radix Stemonae 10-30 part, Radix Scutellariae 10-30 part, Rhizoma Coptidis 10-30 part, Rhizoma Atractylodis 20-30 part, Pericarpium Citri Reticulatae 10-30 part, Poria 10-30 part.
4. the Chinese medicine composition for the treatment of pompholyx according to claim 3, is characterized in that raw material composition and the weight proportion thereof of making the said composition effective ingredient are: 30 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Schizonepetae, 30 parts of Fructus Cnidiis, 20 parts of Alumens, 20 parts of Cortex Dictamni, 20 parts of Radix Saposhnikoviaes, 20 parts of the Radixs Stemonae, 20 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Rhizoma Atractylodis, 20 parts of Pericarpium Citri Reticulataes, 20 parts, Poria.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310065218.0A CN103083601B (en) | 2013-03-01 | 2013-03-01 | Traditional Chinese medical composition for treating pompholyx |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310065218.0A CN103083601B (en) | 2013-03-01 | 2013-03-01 | Traditional Chinese medical composition for treating pompholyx |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103083601A true CN103083601A (en) | 2013-05-08 |
| CN103083601B CN103083601B (en) | 2014-04-09 |
Family
ID=48197079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310065218.0A Expired - Fee Related CN103083601B (en) | 2013-03-01 | 2013-03-01 | Traditional Chinese medical composition for treating pompholyx |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103083601B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104888057A (en) * | 2015-06-26 | 2015-09-09 | 隋缘 | Cleansing solution for curing dyshidrosis |
| CN105477570A (en) * | 2014-09-17 | 2016-04-13 | 李丹 | Pompholyx treating traditional Chinese medicine composition |
| CN106421729A (en) * | 2016-12-07 | 2017-02-22 | 李鹏 | Solution for treating dyshidrosis |
| CN113509512A (en) * | 2021-07-30 | 2021-10-19 | 谢吉伟 | Traditional Chinese medicine for treating herpes zoster and postherpetic pain and preparation method thereof |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1292268A (en) * | 2000-04-24 | 2001-04-25 | 缪振兴 | Medicine for curing tinea unguium |
| CN1413627A (en) * | 2002-05-04 | 2003-04-30 | 付研彪 | Medicine for treating dematosis |
| CN101120986A (en) * | 2006-08-09 | 2008-02-13 | 林朝文 | Body-clearing itching-relieving liquid |
| CN101537149A (en) * | 2008-03-21 | 2009-09-23 | 北京中泰天和科技有限公司 | Pharmaceutical composition for curing eczema |
| CN101537110A (en) * | 2009-05-08 | 2009-09-23 | 姚洪奎 | Soup for detoxifying, removing dampness and relieving itching |
| CN102475813A (en) * | 2010-11-22 | 2012-05-30 | 刘宝环 | Medicament for treating eczema |
| CN102614282A (en) * | 2012-04-25 | 2012-08-01 | 董宜忠 | Medicament for treating eczema and preparation method thereof |
| CN102671084A (en) * | 2012-04-21 | 2012-09-19 | 廖天源 | Medicine of male genital organ cleaning lotion and preparation method thereof |
| CN102716392A (en) * | 2012-06-01 | 2012-10-10 | 蒋金洲 | External-use traditional Chinese medicine composition for treating sores, abscess and herpes |
-
2013
- 2013-03-01 CN CN201310065218.0A patent/CN103083601B/en not_active Expired - Fee Related
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1292268A (en) * | 2000-04-24 | 2001-04-25 | 缪振兴 | Medicine for curing tinea unguium |
| CN1413627A (en) * | 2002-05-04 | 2003-04-30 | 付研彪 | Medicine for treating dematosis |
| CN101120986A (en) * | 2006-08-09 | 2008-02-13 | 林朝文 | Body-clearing itching-relieving liquid |
| CN101537149A (en) * | 2008-03-21 | 2009-09-23 | 北京中泰天和科技有限公司 | Pharmaceutical composition for curing eczema |
| CN101537110A (en) * | 2009-05-08 | 2009-09-23 | 姚洪奎 | Soup for detoxifying, removing dampness and relieving itching |
| CN102475813A (en) * | 2010-11-22 | 2012-05-30 | 刘宝环 | Medicament for treating eczema |
| CN102671084A (en) * | 2012-04-21 | 2012-09-19 | 廖天源 | Medicine of male genital organ cleaning lotion and preparation method thereof |
| CN102614282A (en) * | 2012-04-25 | 2012-08-01 | 董宜忠 | Medicament for treating eczema and preparation method thereof |
| CN102716392A (en) * | 2012-06-01 | 2012-10-10 | 蒋金洲 | External-use traditional Chinese medicine composition for treating sores, abscess and herpes |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105477570A (en) * | 2014-09-17 | 2016-04-13 | 李丹 | Pompholyx treating traditional Chinese medicine composition |
| CN104888057A (en) * | 2015-06-26 | 2015-09-09 | 隋缘 | Cleansing solution for curing dyshidrosis |
| CN106421729A (en) * | 2016-12-07 | 2017-02-22 | 李鹏 | Solution for treating dyshidrosis |
| CN113509512A (en) * | 2021-07-30 | 2021-10-19 | 谢吉伟 | Traditional Chinese medicine for treating herpes zoster and postherpetic pain and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103083601B (en) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272199B (en) | Frostbite treatment medicine | |
| CN103083601B (en) | Traditional Chinese medical composition for treating pompholyx | |
| CN101757313A (en) | Liquid medicine with acupuncture effect | |
| CN102552816B (en) | Plaster for treating pain and preparation method thereof | |
| CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN106620400A (en) | Wine drug for treating chronic pain damage | |
| CN106266939A (en) | A kind of Chinese medicine composition, the transdermal patch for neck waist rehabilitation comprising this Chinese medicine composition and preparation and application | |
| CN102949680B (en) | Medicinal liquor for treating cervical spondylosis and preparation method thereof | |
| CN102652805A (en) | Medicine for treating rabies | |
| CN104027532A (en) | Traditional Chinese medicine fomentation paste for treating rheumatism | |
| CN106177819A (en) | A kind of external medicine composition for cervical spondylosis, preparation method and applications | |
| CN103446502A (en) | Traditional Chinese medicine for treating solar dermatitis | |
| CN105832947A (en) | Health-care foot-soaking Chinese herbal medicine powder | |
| CN103800730A (en) | Foot bath powder | |
| CN104083568A (en) | Miao medicine plaster for ostealgia and preparation method thereof | |
| CN104288597B (en) | A kind of Chinese medicine composition for treating herpes zoster | |
| CN103446310B (en) | Traditional Chinese medicine medicated bath for treating lumbago and leg pain and preparation method thereof | |
| CN102949507B (en) | Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof | |
| CN103182061B (en) | Plaster for treating cervical spondylosis and lumbar diseases | |
| CN105998223A (en) | Medicinal liquid for acupuncture and moxibustion for treating herniation of cervical disc and preparation method thereof | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN110151956A (en) | A kind of blood circulation activating plaster | |
| CN105616638A (en) | Traditional Chinese medicinal lotion for treating infantile eczema | |
| CN103330792B (en) | Traditional Chinese medicine lotion for treating tinea pedes | |
| CN107375547A (en) | A kind of treat triggers the violent Chinese medicine of headache by chill |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140409 Termination date: 20160301 |